These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12895680)

  • 1. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism.
    Schwarz MJ; Houghton PJ; Rose S; Jenner P; Lees AD
    Pharmacol Biochem Behav; 2003 Jun; 75(3):627-33. PubMed ID: 12895680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease.
    Samoylenko V; Rahman MM; Tekwani BL; Tripathi LM; Wang YH; Khan SI; Khan IA; Miller LS; Joshi VC; Muhammad I
    J Ethnopharmacol; 2010 Feb; 127(2):357-67. PubMed ID: 19879939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition, standardization and chemical profiling of Banisteriopsis caapi, a plant for the treatment of neurodegenerative disorders relevant to Parkinson's disease.
    Wang YH; Samoylenko V; Tekwani BL; Khan IA; Miller LS; Chaurasiya ND; Rahman MM; Tripathi LM; Khan SI; Joshi VC; Wigger FT; Muhammad I
    J Ethnopharmacol; 2010 Apr; 128(3):662-71. PubMed ID: 20219660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of Banisteriopsis caapi (B. caapi) on the motor deficits in the MPTP-treated common marmoset model of Parkinson's disease.
    Fisher R; Lincoln L; Jackson MJ; Abbate V; Jenner P; Hider R; Lees A; Rose S
    Phytother Res; 2018 Apr; 32(4):678-687. PubMed ID: 29368409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Components of
    Santos BWL; Moreira DC; Borges TKDS; Caldas ED
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458698
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition.
    Iurlo M; Leone G; Schilström B; Linnér L; Nomikos G; Hertel P; Silvestrini B; Svensson H
    Psychopharmacology (Berl); 2001 Dec; 159(1):98-104. PubMed ID: 11797076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
    Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
    Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
    Callaway JC
    J Psychoactive Drugs; 2005 Jun; 37(2):151-5. PubMed ID: 16149328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.
    Treseder SA; Rose S; Summo L; Jenner P
    J Neural Transm (Vienna); 2003 Mar; 110(3):229-38. PubMed ID: 12658372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.
    Morales-García JA; de la Fuente Revenga M; Alonso-Gil S; Rodríguez-Franco MI; Feilding A; Perez-Castillo A; Riba J
    Sci Rep; 2017 Jul; 7(1):5309. PubMed ID: 28706205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodiversity of β-Carboline Profile of
    Santos BWL; Oliveira RC; Sonsin-Oliveira J; Fagg CW; Barbosa JBF; Caldas ED
    Plants (Basel); 2020 Jul; 9(7):. PubMed ID: 32660098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).
    Herraiz T; González D; Ancín-Azpilicueta C; Arán VJ; Guillén H
    Food Chem Toxicol; 2010 Mar; 48(3):839-45. PubMed ID: 20036304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD; Urichuk LJ; Morley P; Durkin J; Shan JJ; Pang PK; Coutts RT
    J Pharm Pharmacol; 2000 Apr; 52(4):451-9. PubMed ID: 10813558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis.
    Callaway JC; Brito GS; Neves ES
    J Psychoactive Drugs; 2005 Jun; 37(2):145-50. PubMed ID: 16149327
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Djamshidian A; Bernschneider-Reif S; Poewe W; Lees AJ
    Mov Disord Clin Pract; 2016; 3(1):19-26. PubMed ID: 30713897
    [No Abstract]   [Full Text] [Related]  

  • 18. The Design and Evaluation of an l-Dopa-Lazabemide Prodrug for the Treatment of Parkinson's Disease.
    Hoon M; Petzer JP; Viljoen F; Petzer A
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
    Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
    Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
    Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
    J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.